Nat Prod Sci.  2016 Sep;22(3):193-200. 10.20307/nps.2016.22.3.193.

Bioassay-Guided Isolation and Identification of Compounds from Arecae Pericarpium with Anti-inflammatory, Anti-oxidative, and Melanogenesis Inhibition Activities

• Indriana A
• Lee KJ
• Kim YS

• KMID: 2355145
• DOI: http://doi.org/10.20307/nps.2016.22.3.193

Abstract

This study describes the anti-inflammatory, anti-oxidant, and melanogenesis inhibition activities of methanol extract and various organic solvent fractions of Arecae Pericarpium. We examined the inhibition of lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW 264.7 cells, 1,1-diphenyl-2-picrylhydrazine (DPPH) scavenging activity, mushroom tyrosinase inhibition activity and melanin contents. The study showed that, among all tested fractions, methylene chloride fraction showed the strongest inhibition of LPS-induced NO production in RAW 264.7 cells (ICâ‚…â‚€ value 8.89 µg/mL) and DPPH radical scavenging activity (ECâ‚…â‚€ value 21.39 µg/mL). Methylene chloride and ethyl acetate fractions similarly inhibited mushroom tyrosinase activity. Methanol extract exhibited strongest reduction of melanin content in B16F10 melanoma cells. Based on the bioactivity assay results, methylene chloride and ethyl acetate fractions were further separated. Eight phenolic compounds were isolated, which are dimeric syringol (1), catechol (2), 4-hydroxybenzaldehyde (3), vanillin (4), 4-hydroxyacetophenone (5), apocynin (6), protocatechuic acid (7) and 4-hydroxybenzoic acid (8). Among the isolated compounds tested, catechol showed the strongest inhibition of LPS-induced NO production in RAW 264.7 cells. Catechol also showed the concentration-dependent NF-κB inhibition activity. Arecae Pericarpium might have potentials to be developed as anti-inflammatory agent or dermatological product for skin-whitening agent.

Keyword

Arecae Pericarpium; Anti-inflammatory; Antioxidative; Melanogensis Inhibition; Bioassay-guided isolation

MeSH Terms

Agaricales
Areca*
Melanins
Melanoma
Methanol
Methylene Chloride
Monophenol Monooxygenase
Nitric Oxide
Phenol
RAW 264.7 Cells
Melanins
Methanol
Methylene Chloride
Monophenol Monooxygenase
Nitric Oxide
Phenol

Figure

• 

  Fig. 1. Effect of Arecae Pericarpium fractions on (A) LPS-induced NO production and (B) Cell viability in RAW 264.7 cells.

• 

  Fig. 2. DPPH scavenging activity of Arecae Pericarpium fractions.

• 

  Fig. 3. Mushroom tyrosinase inhibition activity of Arecae Pericarpium fractions.

• 

  Fig. 4. Effect of Arecae Pericarpium extract and fractions on (A) Extracellular melanin content (B) Intracellular melanin content (C) Cell viability in B1F10 melanoma cells.

• 

  Fig. 5. Isolation scheme of Arecae Pericarpium methylene chloride fraction.

• 

  Fig. 6. Isolation scheme of Arecae Pericarpium ethyl acetate fraction.

• 

  Fig. 7. Effect of isolated compounds on (A) NO production and (B) cell viability and (C) NF-κ B inhibition activity of syringol and catechol.

• 

  Fig. 8. Isolated phenolic compounds from Arecae Pericarpium MC and EA fractions.

Reference

(1). Peng W., Liu Y. J., Wu N., Sun T., He X. Y., Gao Y. X., Wu C. J. J.Ethnopharmacol. 2015; 164:340–356.

(2). Yenjit P., Issarakraisila M., Intana W., Chantrapromma Kan. Postharvest Biol Technol. 2010; 55:129–132.

(3). Phaechamud T., Toprasri P., Chinpaisal C.Pharm. Biol. 2009; 47:242–247.

(4). Zamora R., Vodovotz Y., Billiar T. R.Mol Med. 2000; 6:347–373.

(5). Korhonen R., Lahti A., Kankaanranta H., Moilanen E.Curr. Drug Targets Inflamm. Allergy. 2005; 4:471–479.

(6). Sun J., Zhang X., Broderick M., Fein H.Sensors. 2003; 3:276–284.

(7). Kim Y. J., Uyama H.Cell Mol. Life Sci. 2005; 62:1707–1723.

(8). Briganti S., Camera E., Picardo M.Pigment Cell Res. 2003; 16:101–110.

(9). Lee K. K., Choi J. D. J.Cosmet. Sci. 1998; 49:351–359.

(10). Moon K. Y., Hahn B. S., Lee J., Kim Y. S.Anal. Biochem. 2001; 292:17–21.

(11). Prieto J. M.Procedure: Preparation of DPPH Radical, and antioxidant scavenging assay. 2012; https://www.researchgate.net/file. as of Jan. 10, 2016.

(12). Zhang W. M., Li B., Han L., Zhang H. D. Afr. J.Biotechnol. 2009; 8:3887–3892.

(13). Tsukamoto K., Jackson I. J., Urabe K., Montague P. M., Hearing V. J.EMBO J. 1992; 11:519–526.